Influence of the combination of SGLT2 inhibitors and GLP-1 receptor agonists on eGFR decline in type 2 diabetes: post-hoc analysis of RECAP study

Overview of attention for article published in Frontiers in Pharmacology, March 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (56th percentile)

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Preprint in Research Square (June 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.